The third Conference on Bioinformatics and Translational Medicine was held in Beijing, from Oct 18 to 19. Themed “Artificial Intelligence-Empowered Translational Medicine”, it gathered dozens of experts who delivered presentations, as well as about 500 participants from clinical, research, industrial and investment sectors.

Participants of the third Conference on Bioinformatics and Translational Medicine pose for a group photo. [Photo/WeChat account: BSC]

The event was jointly hosted by the Academic Subgroup of Biomedical Information at the Biophysical Society of China (BSC), the Interdisciplinary Center for Biointelligence of the Institute of Biophysics at the Chinese Academy of Sciences (CAS) and Beijing Tsinghua Changgung Hospital.

Bo Xiaochen, chair of the conference and president of the BSC Academic Subgroup of Biomedical Information, delivers an opening speech. [Photo/WeChat account: BSC]

Speaking at the opening ceremony, Bo Xiaochen, chair of the conference and president of the BSC Academic Subgroup of Biomedical Information, stated that the meeting aims to implement the country’s innovation-driven development strategy and the goals of the Healthy China 2030 campaign.

He noted that the conference serves to share and discuss how AI can empower multidisciplinary innovation in life sciences, clinical medicine, scientific instrumentation and diagnostics, and promote the application of cutting-edge technologies in clinical and industrial fields. It also seeks to jointly explore a new paradigm for translational medicine with Chinese characteristics and world-class standards, injecting robust scientific and technological impetus into the building of a Healthy China.

Plenary speakers deliver speeches during the conference. [Photo/WeChat account: BSC] 

Plenary speakers included CAS Academicians Chen Runsheng and Yuan Yingjin, along with leading experts from major hospitals, universities and research institutes such as Beijing Children’s Hospital of Capital Medical University, the Cancer Hospital of the Chinese Academy of Medical Sciences, Shandong University, Central South University, Guangzhou Lab and Peking University.

Their keynote reports covered a wide range of topics, including Perspectives on AI, Synthetic Biology and Its Applications, Integrated Translational Medicine System for Neonatal and Pediatric Genetic Disease Screening, as well as Advances in Cancer Screening, Early Detection and Early Treatment in China. 

On Oct 19, nine parallel sub-forums were held, focusing on areas such as large model applications in biomedicine, pediatric health and AI frontiers, AI-empowered infectious disease prevention, innovations in imaging, and clinical cohort development and translational medicine. 

Two special sessions were also organized. The Meet Editors event, titled Academic Influence and the Path to Publication, invited editors from Genomics, Proteomics & Bioinformatics, Asian Journal of Pharmaceutical Sciences, Phenomics and Science China Life Sciences to exchange views with scholars on academic publishing. The Outstanding Young Talents Showcase presented research and technological achievements by emerging scholars.